Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals
xmlui.dri2xhtml.METS-1.0.item-rights
info:eu-repo/semantics/closedAccessDate
2023Metadata
Show full item recordAbstract
OBJECTIVE: Interstitial lung dis-eases (ILDs) are a group of diffuse parenchymal lung disorders that can be idiopathic [idiopath-ic pulmonary fibrosis (IPF)] or associated with other diseases and are characterized by varying degrees of inflammation and fibrosis with poor prognosis. Several indicators are essential in di-agnosing these individuals and differentiating between IPF and ILD. PATIENTS AND METHODS: The study in -volved 44 IPF patients, 22 ILD (non-IPF) patients, and 24 healthy people. We aimed to compare ILD (non-IPF) and IPF patient groups with each other and with healthy people in terms of interleukin (IL)-1, tumor necrosis factor-alpha (TNF-& alpha;), ma-trix metalloproteinase (MMP)-1, MMP-7, galec-tin (Gal)-3, IL-6, Krebs von den Lungen-6 (KL -6), total antioxidant status (TAS), total oxidant status (TOS), pyruvate kinase (PK), complete blood count (CBC), ferritin, erythrocyte sedi-mentation rate (ESR), and C-reactive protein (CRP) features. Furthermore, it was intended to assess the patient groups in terms of visu-al semi-quantitative score (VSQS) (IPF alone), respiratory function tests (RFT), and 6-minute walk test (6MWT), also potential correlations be-tween these tests and the previously indicated parameters.RESULTS: MMP-1, MMP-7, Gal-3, IL-6, KL-6, forced vital capacity (FVC), % FVC, forced expi-ratory volume in 1 second (FEV1), % FEV1, TAS, TOS, and PK values significantly elevated in IPF and ILD. Weight, IL-1, MMP-1, MMP-7, Gal-3, IL -6, KL-6, % FVC, FEV1, % FEV1, eosinophil count, and % red blood cell distribution width (RDW) val-ues differed between IPF and ILD. VSQS, 6MWT, and PK were substantially linked with MMP-1, MMP-7, Gal-3, IL-6, and KL-6 in IPF. CONCLUSIONS: The factors investigated can be helpful in the diagnosis and distinc-tion of IPF and ILD. In addition to focusing on the inflammatory environment in IPF and ILD patients, oxidant and antioxidant interactions must be studied.